Pulmonary neoplasm final

34
PULMONARY NEOPLASM

Transcript of Pulmonary neoplasm final

Page 1: Pulmonary neoplasm    final

PULMONARY NEOPLASM

Page 2: Pulmonary neoplasm    final

INTRODUCTION

Page 3: Pulmonary neoplasm    final

Lung cancer is malignancy in the epithelium of

the respiratory tract

DEFINITION

Page 4: Pulmonary neoplasm    final

Lung cancer accounts about 6.8% of all

malignancies in India The incidence is estimated to be about

6.6%per one lakh in males1.7per one lakh among in females

INCIDENCE

Page 5: Pulmonary neoplasm    final

Cigarette smoking

Exposure with radioactive isotopes, polycyclic hydro carbons, vinyl chloride, metallurgical ores , and mustard gas.

RISK FACTORS

Page 6: Pulmonary neoplasm    final

cigarette smoking include inhaled toxins, such as as bestos, and

pollutants. ,radon, nikal ,iron iron oxides uranium polycyclic aromatic

hydrocarbons chromates arsenic ,air pollution Working in mines smelting or chemical or petroleum manufacturing

Contd…

ETIOLOGY

Page 7: Pulmonary neoplasm    final

polycyclic aromatic hydrocarbons

chromates,arcenic,air pollution, lung disease,TB pneumonia diet low in fruit and vegetables previous radiotherapy to the chest

Contd..

Page 8: Pulmonary neoplasm    final

PATHOPHYSIOLOGY

Page 9: Pulmonary neoplasm    final

Remote effects of malignancy occur in 10 to

20 per cent of lung cancerclients. These usually result from the secretion of sub stances (e.g., hormones, enzymes and antigens) by the tumor itself. These substances then act on target organs, producing a vari ety of symptoms called paraneoplastic symptoms

Paraneoplastic syndromes

Page 10: Pulmonary neoplasm    final

small cell lung cancer, non-small cell lung cancer

Classification and Staging

Page 11: Pulmonary neoplasm    final

T is the tumors size ,location and degree of

invasion N is the regional node involvement M is distant metastasis

Staging

Page 12: Pulmonary neoplasm    final

Early Asymptomatic until late phase Persistent Cough Dyspnoea Chest and shoulder pain Recurrent temperature Recurrent infection Blood tinged sputum Wheeze Anorexia Weight loss Vomiting Hoarseness of voice  

Clinical Manifestations

Page 13: Pulmonary neoplasm    final

Bone pain Spinal cord compression Chest pain Dysphasia Blurred vision Pleural effusion Horseness of voice Dysphagia Head and neck oedema

Late

Page 14: Pulmonary neoplasm    final

Localized Cough mostly chronic dry cough Breathing symptoms -shortness of breath and strider Changes in sputum -increased amount Hemoptysis Pneumonia Hoarseness of voice chest pain and tightness

Signs symptoms depends upon location of lesion

Page 15: Pulmonary neoplasm    final

Bone pain Head ache Mental status changes Abdominal pain Anorexia Idiopathic weight loss Pancots syndrome Horner's syndrome Pleural effusion Svenalar syndrome

generalized

Page 16: Pulmonary neoplasm    final

CXR CT PET SCAN sputum cytology biopsy thoracoscopy bronchoscopy CBC-WBC RBC BIOPSY Contd..

Assessment and Diagnostic Findings

Page 17: Pulmonary neoplasm    final

MRI FNAC Pleural aspirate cytology Mediastinoscopy Lymph node biopsy Open lung biopsy (rare) esophageal ultrasound (EUS) lung scan spirometry, video assisted

thoracoscopy, pulmonary angiography, lung scan

Contd..

Page 18: Pulmonary neoplasm    final

treatment may involve surgery, radiation therapy, chemotherapy combination of these. immune system therapy (gene therapy, therapy with defined tumor

antigens biological response modifiers)

Management

Page 19: Pulmonary neoplasm    final

includingalkylating agents (ifosfamide),

platinum analogues (cisplatin andcarboplatin), taxanes (paclitaxel, docetaxel), vinca alkaloids(vinblastine and vindesine), doxorubicin, gemcitabine, vinorelbine,irinotecan (CPT-11), and etoposide (VP-16)

CHEMOTHERAPY

Page 20: Pulmonary neoplasm    final

Radiation is used to reduce the size of a

tumor, to make an inoperable tumor operable, relieve the pressure of the tumor on vital

structures. control symptoms of spinal cord metastasis

and superior vena caval compression Reduce bone and liver pain.

RADIATION THERAPY

Page 21: Pulmonary neoplasm    final

diminished cardiopulmonary function pulmonary fibrosis, Pericarditis, myelitis cor pulmonale. pneumonitis. Pulmonary toxicity

 Treatment-Related Complications

Page 22: Pulmonary neoplasm    final

lobotomy (removal of a lobe of the lung). Entire lung may be

removed(pneumonectomy)

SURGICAL MANAGEMENT

Page 23: Pulmonary neoplasm    final

Wedge Resection. Segmental Resection. Segmental Resection. Pneumonectomy.

Types of surgical approaches

Page 24: Pulmonary neoplasm    final

laser use is palliative for the relief of

endobronchial obstructions caused by non resectable lung tumors. Lasers do not produce systemic or cumulative toxic effects and are well tolerated.

LASER THERAPY

Page 25: Pulmonary neoplasm    final

CLOSED CHEST DRAINAGE

Page 26: Pulmonary neoplasm    final

Metastasis.

Page 27: Pulmonary neoplasm    final

sarcomas, lymphomas, bronchial adenomas.

OTHER TYPES OF LUNG TUMORS

Page 28: Pulmonary neoplasm    final

Hamartomas Chondromas Mesotheliomas

Benign tumors.

Page 29: Pulmonary neoplasm    final

Nursing Management

Page 30: Pulmonary neoplasm    final

Ineffective airway clearance related to

increased tracheobronchial secretions and presence of tumor

Anxiety related to lack of knowledge of diagnosis or unknown prognosis and treatments

Acute pain related to pressure of tumor on surrounding structures and erosion of tissues

Nursing Diagnoses

Page 31: Pulmonary neoplasm    final

Imbalanced nutrition: less than body

requirements related to increased metabolic demands, increased secretions, weakness, and anorexia

Ineffective health maintenance related to lack of knowledge about the disease process and therapeutic regimen

Ineffective breathing pattern related to decreased lung capacity.

 

Contd..

Page 32: Pulmonary neoplasm    final

health promotion, managing symptoms relieving breathing problems reducing fatigue providing psychological support acute intervention. ambulatory and home care

Nursing Implementation

Page 33: Pulmonary neoplasm    final

Evidence based practice

Page 34: Pulmonary neoplasm    final

CONCLUSION